Viewing nowEbs Tablet 50 mg (Vildagliptin)
Vildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

MFDS item code 201908043 · Approved 2019.11.22 · Insurance code 650205820
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medicine is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can also be used as monotherapy, and in cases where blood sugar control is difficult with monotherapy in patients without prior experience in diabetes medication, it is administered in combination with metformin. Additionally, it can be administered in combination with either sulfonylurea, metformin, or thiazolidinedione when sufficient blood sugar control is not achieved with any one of these monotherapies. When blood sugar control is difficult with combination therapy of sulfonylurea and metformin, this medicine can also be used as an add-on. Therefore, this medicine is used to improve blood sugar control in various therapeutic situations.
This medicine should be administered at 50mg once daily in the morning, or at 100mg daily as 50mg twice daily, in the morning and evening, for monotherapy or when used in combination with metformin in patients with no previous experience of antidiabetic drug treatment. When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose when this medicine is used in combination with metformin or a thiazolidinedione is 100mg daily, as 50mg twice daily, in the morning and evening. When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose when this medicine is used in combination with a sulfonylurea is 50mg once daily in the morning. In this patient population, once-daily vildagliptin 100mg was not more effective than once-daily 50mg. When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is used in combination (as triple therapy) is 100mg daily, as 50mg twice daily, in the morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is used in combination is 100mg daily, as 50mg twice daily, in the morning and evening. This medicine may be taken with or without food, and doses greater than 100mg daily are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it as soon as you remember and take the next dose at your usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment: This medicine is not recommended for patients with hepatic impairment whose ALT or AST levels before treatment exceed 2.5 times the upper limit of normal. Patients with mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. Patients with moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended.
This medicine should not be used by patients who have had an allergic reaction to the active ingredient or other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic lactose metabolism disorders should not take this medicine. While taking this medicine, liver function abnormalities can occur infrequently, so it is important to have regular liver function tests before and during the course of treatment. If there is severe deterioration in liver function or symptoms of jaundice, treatment should be discontinued immediately. In some heart failure patients, the use of this medicine may be restricted; therefore, follow the doctor's instructions. If abnormal symptoms appear on the skin, such as blisters or ulcers, notify medical personnel immediately, and discontinue the medication if necessary. If symptoms of acute pancreatitis are suspected, the medicine should be stopped immediately, and a hospital visit should be made. When used with other diabetes medications that may cause hypoglycemia, pay attention to hypoglycemic symptoms, and dose adjustment may be needed. If symptoms such as dizziness occur, it is advisable to avoid driving or operating machinery. Women who are pregnant or breastfeeding should avoid using this medicine, and it is not recommended for children and adolescents under 18 years of age. In case of overdose, there is no specific antidote, so symptomatic supportive treatment is necessary, and this medicine cannot be removed by hemodialysis. It should be stored out of reach of children, and transferring to another container should be avoided.
Hepatitis, liver function abnormalities, elevated transaminase levels, angioedema, tremors, headache, dizziness, fatigue, nausea, hypoglycemia, rhinitis, asthenia, constipation, weight gain, peripheral edema, gastroesophageal reflux, diarrhea, bloating, chills, decreased blood sugar, sweating, pancreatitis, urticaria, blisters, exfoliative skin lesions, joint pain with severe conditions and disabilities, cutaneous vasculitis, cholecystitis, upper respiratory infection, acute myocardial infarction, nodular arrhythmia, acute cholecystitis, pneumothorax, cholelithiasis, femoral fracture, peripheral artery disease, supraventricular tachycardia, congestive heart failure, gastric ulcer, gastric cancer, increased INR, appendicitis, pulmonary edema, vertigo, chest discomfort, dyspnea, cough, dyspepsia, drowsiness, pruritus, dry mouth, vomiting, insomnia, renal impairment, lip blisters, hunger, sensory loss, spinal stenosis, abdominal pain, gastroenteritis, gastritis, gastric ulcer, belching, angina, heart failure, cardiac hypertrophy, cardiac arrest, renal cyst, lung cancer, leg pain, increased C-reactive protein
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to air and moisture, so it must be stored in a tightly sealed container. Keeping it in a cool place below 30 degrees Celsius helps maintain its effectiveness.
Round tablet with a white to light yellow color
30 tablets/box [(10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Ahn-Guk New Pharm Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.
Vildagliptin 50mg
Tablet · Prescription medication
Pharmgen Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.